354 Dose Effect Analysis of Sodium Zirconium Cyclosilicate (SZC) in Hyperkalemic Hemodialysis Patients in the DIALIZE Study

American Journal of Kidney Diseases ◽

10.1053/j.ajkd.2020.02.356 ◽

2020 ◽

Vol 75 (4) ◽

pp. 639

Keyword(s):

Hemodialysis Patients ◽

Dose Effect ◽

Effect Analysis ◽

Sodium Zirconium ◽

Sodium Zirconium Cyclosilicate

Download Full-text

Dose effect analysis of sodium zirconium cyclosilicate in hemodialysis patients

Hemodialysis International ◽

10.1111/hdi.12983 ◽

2021 ◽

Author(s):

Bruce Spinowitz ◽

Kieran McCafferty ◽

Steven Fishbane ◽

Masafumi Fukagawa ◽

Nicolas Guzman ◽

...

Keyword(s):

Hemodialysis Patients ◽

Dose Effect ◽

Effect Analysis ◽

Sodium Zirconium ◽

Sodium Zirconium Cyclosilicate

Download Full-text

Effectiveness of Sodium Zirconium Cyclosilicate in Hemodialysis Patients With Severe Hyperkalemia

Kidney International Reports ◽

10.1016/j.ekir.2021.09.004 ◽

2021 ◽

Author(s):

Martin Ford ◽

Steven Fishbane ◽

Bruce Spinowitz ◽

Anjay Rastogi ◽

Nicolas Guzman ◽

...

Keyword(s):

Hemodialysis Patients ◽

Sodium Zirconium ◽

Severe Hyperkalemia ◽

Sodium Zirconium Cyclosilicate

Download Full-text

Faculty Opinions recommendation of Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725238276.793511073 ◽

2015 ◽

Author(s):

WH Wilson Tang

Keyword(s):

Clinical Trial ◽

Randomized Clinical Trial ◽

Sodium Zirconium ◽

Sodium Zirconium Cyclosilicate

Download Full-text

Faculty Opinions recommendation of Sodium zirconium cyclosilicate in hyperkalemia.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.725243590.793503499 ◽

2015 ◽

Author(s):

Kianoush Kashani

Keyword(s):

Sodium Zirconium ◽

Sodium Zirconium Cyclosilicate

Download Full-text

USE OF SODIUM ZIRCONIUM CYCLOSILICATE FOR UP-TITRATION OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM INHIBITOR THERAPY IN PATIENTS WITH HEART FAILURE: A CASE SERIES

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(21)02063-5 ◽

2021 ◽

Vol 77 (18) ◽

pp. 704

Author(s):

Rhys Williams ◽

Alexander James ◽

Moira Ashton ◽

Sian Vaughan ◽

Aaron Wong

Keyword(s):

Heart Failure ◽

Case Series ◽

Inhibitor Therapy ◽

Renin Angiotensin Aldosterone System ◽

Renin Angiotensin ◽

Sodium Zirconium ◽

Patients With Heart Failure ◽

Sodium Zirconium Cyclosilicate

Download Full-text

Clinical utility of patiromer, sodium zirconium cyclosilicate, and sodium polystyrene sulfonate for the treatment of hyperkalemia: an evidence-based review

Core Evidence ◽

10.2147/ce.s129555 ◽

2017 ◽

Vol Volume 12 ◽

pp. 11-24 ◽

Author(s):

Mario Beccari ◽

Calvin Meaney

Keyword(s):

Clinical Utility ◽

Sodium Polystyrene Sulfonate ◽

Evidence Based ◽

Polystyrene Sulfonate ◽

Sodium Zirconium ◽

Sodium Zirconium Cyclosilicate

Download Full-text

In-vitro study of lithium binding by sodium zirconium cyclosilicate (Lokelma®) or patiromer (Veltassa®)

Toxicology Communications ◽

10.1080/24734306.2021.2007602 ◽

2021 ◽

Vol 5 (1) ◽

pp. 161-164

Author(s):

David B. Liss ◽

Stephen M. Roper ◽

Dennis J. Dietzen ◽

Michael E. Mullins

Keyword(s):

In Vitro Study ◽

Vitro Study ◽

Sodium Zirconium ◽

Sodium Zirconium Cyclosilicate

Download Full-text

Sodium zirconium cyclosilicate in hyperkalaemia: a profile of its use

Drugs & Therapy Perspectives ◽

10.1007/s40267-020-00706-0 ◽

2020 ◽

Vol 36 (3) ◽

pp. 89-96

Author(s):

Julia Paik

Keyword(s):

Sodium Zirconium ◽

Sodium Zirconium Cyclosilicate

Download Full-text

FP008ACHIEVEMENT OF NORMAL SERUM POTASSIUM WITH SODIUM ZIRCONIUM CYCLOSILICATE (ZS-9) IN A SUBGROUP OF PATIENTS WITH STAGE 4/5 CHRONIC KIDNEY DISEASE AND BASELINE POTASSIUM ≥5.5 MMOL/L FROM THE PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED HARMONIZE STUDY

Nephrology Dialysis Transplantation ◽

10.1093/ndt/gfv165.08 ◽

2015 ◽

Vol 30 (suppl_3) ◽

pp. iii68-iii68

Author(s):

Simon D. Roger ◽

Angel de Francisco ◽

Henrik Rasmussen ◽

Philip Lavin ◽

Bhupinder Singh ◽

...

Keyword(s):

Chronic Kidney Disease ◽

Kidney Disease ◽

Serum Potassium ◽

Normal Serum ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Sodium Zirconium ◽

Stage 4 ◽

Sodium Zirconium Cyclosilicate

Download Full-text

SAFETY OF SODIUM ZIRCONIUM CYCLOSILICATE (ZS-9) IN HYPERKALEMIA: ANALYSIS OF GI EFFECTS IN THE PHASE 3 HARMONIZE STUDY

American Journal of Kidney Diseases ◽

10.1053/j.ajkd.2015.02.222 ◽

2015 ◽

Vol 65 (4) ◽

pp. A69 ◽

Keyword(s):

Phase 3 ◽

Sodium Zirconium ◽

Sodium Zirconium Cyclosilicate

Download Full-text